Idifarma, a Spanish contract development organization, has obtained authorization from the Spanish Agency of Medicines and Medical Devices to manufacture commercial batches of both conventional and high potency tablets.   With this authorization, the company can manufacture commercial batches of tablets with high level of specialization due to high containment requirements (cytotoxics, cytostatics, hormonals), or the need to manufacture small-sized batches.   Idifarma was previously authorized t...